Literature DB >> 21676902

Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009).

Christine Lascols1, Meredith Hackel, Steven H Marshall, Andrea M Hujer, Sam Bouchillon, Robert Badal, Daryl Hoban, Robert A Bonomo.   

Abstract

OBJECTIVES: To investigate the β-lactamase background of ertapenem non-susceptible isolates for the presence of the most commonly detected carbapenemase genes, bla(KPC), bla(OXA-48) and bla(VIM), and the newly described bla(NDM-1).
METHODS: Two hundred and thirty-five ertapenem-non-susceptible (MIC ≥ 0.5 mg/L) isolates of Enterobacteriaceae from the worldwide Study for Monitoring Antimicrobial Resistance Trends (SMART) 2009 programme were screened using a multiplex PCR for the presence of bla(KPC), bla(OXA-48), bla(VIM) and bla(NDM-1) genes. Extended-spectrum β-lactamase (ESBL) and AmpC genes (bla(ESBL) and bla(AmpC)) were identified using the Check-MDR CT101 microarray. DNA sequencing was performed to identify the bla(ESBL), bla(KPC) and bla(NDM-1) genes. Molecular typing was also performed to genetically characterize these isolates.
RESULTS: Sixty-six isolates (28%) had a carbapenemase gene, with bla(NDM-1) identified in 33 isolates including 2 isolates carrying both bla(NDM-1) and bla(OXA-48); other carbapenemase genes found included bla(KPC) (n = 23), bla(VIM) (n = 7) and bla(OXA-48) (n = 3). All bla(NDM-1)-carrying isolates were from patients in India and comprised five different species. With the exception of one isolate carrying only bla(NDM-1), all bla(NDM-1) carbapenemase-possessing isolates carried additional β-lactamases in various combinations: bla(ESBL) and bla(AmpC) (n = 18); bla(ESBL) (n = 10); bla(ESBL), bla(AmpC) and bla(OXA-48) (n = 2); and bla(AmpC) (n = 2). Except for bla(OXA-48)-carrying isolates, novel multilocus sequence types or enterobacterial repetitive intergenic consensus PCR patterns were observed along with clonal dissemination within and among sites.
CONCLUSIONS: A range of carbapenemase genes, associated with diverse ESBLs and/or AmpC backgrounds, were found among Enterobacteriaceae isolated during the study. Many of these ertapenem non-susceptible strains were clonally related and carried various combinations of β-lactamases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676902      PMCID: PMC3153502          DOI: 10.1093/jac/dkr240

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  26 in total

1.  Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.

Authors:  Caroline Dallenne; Anaelle Da Costa; Dominique Decré; Christine Favier; Guillaume Arlet
Journal:  J Antimicrob Chemother       Date:  2010-01-12       Impact factor: 5.790

Review 2.  Carbapenem-hydrolyzing beta-lactamases.

Authors:  B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

3.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002-2005.

Authors:  E Cambau; C Lascols; W Sougakoff; C Bébéar; R Bonnet; J-D Cavallo; L Gutmann; M-C Ploy; V Jarlier; C-J Soussy; J Robert
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

5.  NDM-2 carbapenemase in Acinetobacter baumannii from Egypt.

Authors:  Martin Kaase; Patrice Nordmann; Thomas A Wichelhaus; Sören G Gatermann; Rémy A Bonnin; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2011-03-21       Impact factor: 5.790

Review 6.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 7.  Metallo-beta-lactamases: a class apart.

Authors:  K Bush
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

8.  Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.

Authors:  Dongeun Yong; Mark A Toleman; Christian G Giske; Hyun S Cho; Kristina Sundman; Kyungwon Lee; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

Review 9.  [KPC carbapenemases: what is at stake in clinical microbiology?].

Authors:  G Cuzon; T Naas; P Nordmann
Journal:  Pathol Biol (Paris)       Date:  2009-10-24

10.  Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.

Authors:  Andrea Endimiani; John M Depasquale; Sandra Forero; Federico Perez; Andrea M Hujer; Daneshia Roberts-Pollack; Paul D Fiorella; Nancy Pickens; Brandon Kitchel; Aida E Casiano-Colón; Fred C Tenover; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2009-09-09       Impact factor: 5.790

View more
  63 in total

1.  Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals.

Authors:  Yvonne Pfeifer; Kathrin Schlatterer; Elisabeth Engelmann; Reinhold A Schiller; Hans Reiner Frangenberg; Doris Stiewe; Martin Holfelder; Wolfgang Witte; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  NDM-1 and the Role of Travel in Its Dissemination.

Authors:  Mary Elizabeth Wilson; Lin H Chen
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

3.  NDM-1-producing Klebsiella pneumoniae in Mauritius.

Authors:  Laurent Poirel; Christine Lascols; Sandrine Bernabeu; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

4.  Detection of Antibiotic Resistance Determinants and Their Transmissibility among Clinically Isolated Carbapenem-Resistant Escherichia coli from South India.

Authors:  Niranjana Mahalingam; Bhavani Manivannan; Balaram Khamari; Shivakumara Siddaramappa; Sudeshna Adak; Eswarappa Pradeep Bulagonda
Journal:  Med Princ Pract       Date:  2018-05-08       Impact factor: 1.927

5.  A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations.

Authors:  Agila Kumari Pragasam; Rani Diana Sahni; Shalini Anandan; Archa Sharma; Radha Gopi; Noorjahan Hadibasha; Priya Gunasekaran; Balaji Veeraraghavan
Journal:  J Clin Diagn Res       Date:  2016-07-01

6.  OXA-181 Beta Lactamase is not a Major Mediator of Carbapenem Resistance in Enterobacteriaceae.

Authors:  M Shanthi; Uma Sekar; Arunagiri K; Hemant Goverdhandas Bramhne
Journal:  J Clin Diagn Res       Date:  2013-09-10

7.  Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.

Authors:  David van Duin; Eric Cober; Sandra S Richter; Federico Perez; Robert C Kalayjian; Robert A Salata; Scott Evans; Vance G Fowler; Keith S Kaye; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2014-12-09       Impact factor: 5.790

8.  Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase.

Authors:  Mariano M González; Magda Kosmopoulou; Maria F Mojica; Valerie Castillo; Philip Hinchliffe; Ilaria Pettinati; Jürgen Brem; Christopher J Schofield; Graciela Mahler; Robert A Bonomo; Leticia I Llarrull; James Spencer; Alejandro J Vila
Journal:  ACS Infect Dis       Date:  2015-07-20       Impact factor: 5.084

9.  Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.

Authors:  Laura J Rojas; Madiha Salim; Eric Cober; Sandra S Richter; Federico Perez; Robert A Salata; Robert C Kalayjian; Richard R Watkins; Steve Marshall; Susan D Rudin; T Nicholas Domitrovic; Andrea M Hujer; Kristine M Hujer; Yohei Doi; Keith S Kaye; Scott Evans; Vance G Fowler; Robert A Bonomo; David van Duin
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

10.  Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.

Authors:  Jasmine Ahmed-Bentley; A Uma Chandran; A Mark Joffe; Desiree French; Gisele Peirano; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.